Cargando…
Dystrophic epidermolysis bullosa: a review
Dystrophic epidermolysis bullosa is a rare inherited blistering disorder caused by mutations in the COL7A1 gene encoding type VII collagen. The deficiency and/or dysfunction of type VII collagen leads to subepidermal blistering immediately below the lamina densa, resulting in mucocutaneous fragility...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4451851/ https://www.ncbi.nlm.nih.gov/pubmed/26064063 http://dx.doi.org/10.2147/CCID.S54681 |
_version_ | 1782374206702354432 |
---|---|
author | Shinkuma, Satoru |
author_facet | Shinkuma, Satoru |
author_sort | Shinkuma, Satoru |
collection | PubMed |
description | Dystrophic epidermolysis bullosa is a rare inherited blistering disorder caused by mutations in the COL7A1 gene encoding type VII collagen. The deficiency and/or dysfunction of type VII collagen leads to subepidermal blistering immediately below the lamina densa, resulting in mucocutaneous fragility and disease complications such as intractable ulcers, extensive scarring, malnutrition, and malignancy. The disease is usually diagnosed by immunofluorescence mapping and/or transmission electron microscopy and subsequently subclassified into one of 14 subtypes. This review provides practical knowledge on the disease, including new therapeutic strategies. |
format | Online Article Text |
id | pubmed-4451851 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-44518512015-06-10 Dystrophic epidermolysis bullosa: a review Shinkuma, Satoru Clin Cosmet Investig Dermatol Review Dystrophic epidermolysis bullosa is a rare inherited blistering disorder caused by mutations in the COL7A1 gene encoding type VII collagen. The deficiency and/or dysfunction of type VII collagen leads to subepidermal blistering immediately below the lamina densa, resulting in mucocutaneous fragility and disease complications such as intractable ulcers, extensive scarring, malnutrition, and malignancy. The disease is usually diagnosed by immunofluorescence mapping and/or transmission electron microscopy and subsequently subclassified into one of 14 subtypes. This review provides practical knowledge on the disease, including new therapeutic strategies. Dove Medical Press 2015-05-26 /pmc/articles/PMC4451851/ /pubmed/26064063 http://dx.doi.org/10.2147/CCID.S54681 Text en © 2015 Shinkuma. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Review Shinkuma, Satoru Dystrophic epidermolysis bullosa: a review |
title | Dystrophic epidermolysis bullosa: a review |
title_full | Dystrophic epidermolysis bullosa: a review |
title_fullStr | Dystrophic epidermolysis bullosa: a review |
title_full_unstemmed | Dystrophic epidermolysis bullosa: a review |
title_short | Dystrophic epidermolysis bullosa: a review |
title_sort | dystrophic epidermolysis bullosa: a review |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4451851/ https://www.ncbi.nlm.nih.gov/pubmed/26064063 http://dx.doi.org/10.2147/CCID.S54681 |
work_keys_str_mv | AT shinkumasatoru dystrophicepidermolysisbullosaareview |